Home›Stock Screener›3B BlackBio DX›Quarterly Results

3B BlackBio DX Quarterly Results

Latest Quarter Net Profit
₹10 Cr
QMar 2026
Quarterly Results

3B BlackBio DX quarterly results. In Mar 2026, 3B BlackBio DX (3BBLACKBIO) reported revenue ₹46 Cr and net profit ₹10 Cr — revenue +70.4% YoY. Review 3BBLACKBIO price earnings ratio to evaluate earnings-based valuation against sector peers.

3BBLACKBIO Quarterly Results — Revenue, Profit & EPS Highlights

3B BlackBio DX latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Check 3B BlackBio DX market cap to track the company's total market size over time.

  • Revenue of ₹46 Cr in Mar 2026 (+15.0% vs Jun 2026, +70.4% vs Mar 2025)
  • Net Profit of ₹10 Cr in Mar 2026 (+11.1% vs Jun 2026, +25.0% vs Mar 2025)
  • EBITDA of ₹19 Cr in Mar 2026 (+26.7% vs Jun 2026)
  • Operating Margin of 24.0% in Mar 2026 (-1.0pp vs Jun 2026)
  • Earnings Per Share of ₹11.44 in Mar 2026 (+9.2% vs Jun 2026)

3B BlackBio DX Quarterly Results — Revenue, EBITDA, Net Profit & EPS

3BBLACKBIO quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 46 40 39 27 27 15.0% 70.4%
Net Profit (₹ Cr) 10 9 15 8 13 - -
EBITDA (₹ Cr) 19 15 20 13 16 - -
EPS (₹) 11.44 10.48 17.55 9.38 14.76 - -
Operating Margin (%) 24.0% 25.0% 43.0% 35.0% 53.0% - -

3BBLACKBIO Share Price Trend — 1-Year Movement Across Quarterly Results

3B BlackBio DX 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit 3B BlackBio DX share price today.

Profitability Ratios

Profit Margin 21.7%
EBITDA Margin 41.3%
Operating Margin 24.0%
ROE (Annual) 12.3%

Balance Sheet Highlights

Total Assets ₹378 Cr
Total Equity ₹324 Cr
Current Assets ₹193 Cr
Current Liabilities ₹10 Cr

Cash Flow Analysis

Operating Cash Flow ₹43 Cr
Investing Cash Flow ₹-34 Cr
Financing Cash Flow ₹-3 Cr
Net Cash Flow ₹7 Cr

Current Market Data

Current Price ₹1624.70
Exchange NSE
Last Updated Oct 05, 2026

Revenue Trend (₹ Cr)

Mar 2025 27
Sept 2025 39
Jun 2026 40
Mar 2026 46

Net Profit Trend (₹ Cr)

Mar 2025 8
Sept 2025 15
Jun 2026 9
Mar 2026 10

Operating Margin Trend (%)

Mar 2025 35.0%
Sept 2025 43.0%
Jun 2026 25.0%
Mar 2026 24.0%

3BBLACKBIO vs Healthcare Services Peers — Quarterly Revenue, Profit & Market Cap

3B BlackBio DX latest quarter revenue and net profit vs Healthcare Services competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Apollo Hospitals
Mar 2026 		₹116,947.25 Cr 7985.0 6,660 551 -6.3% - 8.3% 216.9
Max Healthcare Inst…
Mar 2026 		₹87,841.25 Cr 917.0 2,191 342 -9.0% - 15.6% 260.5
Fortis Healthcare
Mar 2026 		₹57,663.70 Cr 763.8 2,375 271 -7.7% - 11.4% 217.0
Aster DM Healthcare
Mar 2026 		₹42,146.56 Cr 691.5 1,219 154 -0.6% +18.1% 12.6% 254.2
Global Health
Mar 2026 		₹38,047.48 Cr 1332.6 1,196 142 -9.8% - 11.9% 248.6
Sector Quarterly Performance Comparison
Healthcare Services sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores